Article Sidebar
Views pdf: 80
CLINICAL AND SUBCLINICAL FEATURES OF INFLAMMATORY BOWEL DISEASE AT THE GASTROINTESTINAL-HEPATOLOGY CENTER, BACH MAI HOSPITAL IN 2022-2023
Main Article Content
Abstract
Objective: To describe clinical and subclinical features of inflammatory bowel disease at the gastrointestinal-hepatology center of Bach Mai hospital in 2022 – 2023. Subjects and methods: Subjects and methods: A cross-sectional descriptive study on 247 patients treated at Bach Mai Hospital from January 2022 to December 2023. Results: The average age of the study was 41.99, with 56.3% of men. The main clinical symptoms of inflammatory bowel disease were abdominal pain, digestive disorders and bloody stools. According to the Montreal classification, Crohn's disease was most commonly diagnosed in the 17-39 age group, often occurring in the ileum and rarely in the upper gastrointestinal tract. A majority of patients had extensive ucerative colitis (UC). 81% of patients had at least one severe prognostic factor. 30.4% of patients with inflammatory bowel disease had to undergo surgery due to complications, mainly Crohn's disease. Conclusion: Inflammatory bowel disease includes Crohn's disease and ulcerative colitis with diverse clinical manifestations. Hospitalized patients have severe prognostic factors, and many patients require surgery due to complications of the disease.
Article Details
Keywords
Inflammatory bowel disease, Crohn’s disease, ulcerative colitis
References
2. Maaser, C.; Sturm, A.; Vavricka, S. R.; Kucharzik, T.; Fiorino, G.; Annese, V.; Calabrese, E.; Baumgart, D. C.; Bettenworth, D.; Borralho Nunes, P.; Burisch, J.; Castiglione, F.; Eliakim, R.; Ellul, P.; González-Lama, Y.; Gordon, H.; Halligan, S.; Katsanos, K.; Kopylov, U.; Kotze, P. G.; Krustiņš, E.; Laghi, A.; Limdi, J. K.; Rieder, F.; Rimola, J.; Taylor, S. A.; Tolan, D.; van Rheenen, P.; Verstockt, B.; Stoker, J. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial Diagnosis, Monitoring of Known IBD, Detection of Complications. Journal of Crohn’s and Colitis 2019, 13 (2), 144-164K. https://doi.org/10.1093/ecco-jcc/jjy113.
3. Ng, S. C.; Tang, W.; Ching, J. Y.; Wong, M.; Chow, C. M.; Hui, A. J.; Wong, T. C.; Leung, V. K.; Tsang, S. W.; Yu, H. H.; Li, M. F.; Ng, K. K.; Kamm, M. A.; Studd, C.; Bell, S.; Leong, R.; Silva, H. J. de; Kasturiratne, A.; Mufeena, M. N. F.; Ling, K. L.; Ooi, C. J.; Tan, P. S.; Ong, D.; Goh, K. L.; Hilmi, I.; Pisespongsa, P.; Manatsathit, S.; Rerknimitr, R.; Aniwan, S.; Wang, Y. F.; Ouyang, Q.; Zeng, Z.; Zhu, Z.; Chen, M. H.; Hu, P. J.; Wu, K.; Wang, X.; Simadibrata, M.; Abdullah, M.; Wu, J. C.; Sung, J. J. Y.; Chan, F. K. L. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn’s and Colitis Epidemiology Study. Gastroenterology 2013, 145 (1), 158-165.e2. https://doi.org/10.1053/j.gastro.2013.04.007.
4. Ngà Đ. T.; Bình N. C.; Kỳ T. D.; Tùng N. L.; Ngân H. K.; Quang P. M. N.; Tuyết D. T.; Hoài M. T.; Loan P. T. C.; Thuận L. T.; Ánh B. T. Biểu hiện lâm sàng tại ruột và ngoài ruột của bệnh nhân viêm ruột mạn tại Bệnh viện Trung ương Quân đội 108. Journal of 108 - Clinical Medicine and Phamarcy 2023. https://doi.org/ 10.52389/ydls.v18i3.1816.
5. Carter, M. J.; Lobo, A. J.; Travis, S. P. L.; IBD Section, British Society of Gastroenterology. Guidelines for the Management of Inflammatory Bowel Disease in Adults. Gut 2004, 53 Suppl 5 (Suppl 5), V1-16. https://doi.org/ 10.1136/gut.2004.043372.
6. Freeman, H. J. Application of the Montreal Classification for Crohn’s Disease to a Single Clinician Database of 1015 Patients. Can J Gastroenterol 2007, 21 (6), 363–366.